Komori
Share Issuance and Disposal4591RIBOMIC Inc.Pharmaceuticals

Notice Regarding a Reduction in the Amounts of Capital and Capital Reserve and the Disposal of Surplus

The Company will submit to the shareholders meeting a proposal to transfer ¥822,380,030 from capital stock and ¥2,366,157,532 from capital reserve to other capital surplus, and apply the entire amount to offset the deficit in retained earnings brought forward. This is an accounting reclassification of account items, and will not change total net assets or the total number of issued shares.

Worth reading
25Immaterial
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
3188537562
¥
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Reduction of capital and capital reserves and disposition of surplus

発行・処分する株式数

Not applicable (the total number of issued shares will not change)

Intended allottee
None
Total Stock-Based Compensation

None

Specific use of funds
Not applicable (this is not a fundraising transaction)
発行済株式総数

No change

0% (the total number of issued shares will not change)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Conditions on transfer restrictions

Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.

Transfer restriction period
None
Conditions for lifting transfer restrictions
None
Reason for acquisition without consideration
None
Offering structure
Underwriter / lead underwriter
None
Overallotment
None
Stock Split RatioNone
Categories and Number of Persons Covered
None
Intended allottee's holding policy
None
Payment date
None
Basis for determining the amount to be paid
None
Procedures under the Corporate Code of Conduct
The matter is scheduled to be submitted to the 23rd Annual General Meeting of Shareholders, scheduled for 23 June 2026.
Impact on Business Performance
This matter will have no impact on the Company's financial results.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalReduction of capital and capital reserves and disposition of surplus
Number of shares to be issued or disposed ofNot applicable (the total number of issued shares will not change)
Specific use of fundsNot applicable (this is not a fundraising transaction)
Payment dateNone
Intended allotteeNone
Intended allottee's holding policyNone
Dilution Rate0% (the total number of issued shares will not change)
Total number of issued sharesNo change
Basis for determining the amount to be paidNone
Transfer restriction periodNone
Conditions for lifting transfer restrictionsNone
Reason for acquisition without considerationNone
Categories and Number of Persons CoveredNone
Total Stock-Based CompensationNone
Underwriter / lead underwriterNone
OverallotmentNone
Stock Split RatioNone
Procedures under the Corporate Code of ConductThe matter is scheduled to be submitted to the 23rd Annual General Meeting of Shareholders, scheduled for 23 June 2026.
Impact on Business PerformanceThis matter will have no impact on the Company's financial results.
Items this document does not state (9)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesExercise priceExercise periodNumber of Stock Acquisition RightsMost recent equity financingMajor shareholders after the offering

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To offset the deficit in retained earnings brought forward of ¥3,188,537,562, reduce the tax burden and strengthen the Company's financial position.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding a Reduction in the Amounts of Capital and Capital Reserve and the Disposal of Surplus | RIBOMIC Inc. (4591) timely disclosure | Komori